Quantification of two fluorophores' concentration ratio in a mice model in preparation for a proposed method for early detection of Alzheimer's disease

Osnat Harbater, Margalit Efrati, Israel Gannot

Research output: Contribution to journalArticle

Abstract

Many biomedical applications require concentration measurements of biological compounds, which may be achieved using targeted fluorescent probes. It has been shown that the ratio between amyloid-Beta and tau protein in the cerebrospinal fluid (CSF) is a good indicator of incipient Alzheimer's disease (AD).We have previously proposed a method that can accurately estimate the concentration ratio of these two proteins without the need to collect CSF samples: Fluorescent probes are injected to the blood and bind to the CSF biomarkers. A miniature needle with an optical fiber excites the fluorescent probes and collects the fluorescence emission. The concentration ratio between the proteins is estimated, and used for diagnosis of incipient AD. We present here the results of the method's concentration ratio estimation during trials performed on mice. Miniature tubes containing two fluorescent probes in several concentration ratios were implanted in two locations in the mice: subcutaneously, and deeper in the abdomen. The fluorescent probes were excited and the fluorescence intensity was measured. The concentration ratios were estimated from the fluorescence intensities with an average error of less than 20%. This study is a step towards the demonstration of the method in in vivo studies in mice with markers in the bloodstream/CSF.

Original languageEnglish (US)
Article number745
JournalApplied Sciences (Switzerland)
Volume8
Issue number5
DOIs
StatePublished - May 8 2018

Fingerprint

Fluorophores
Cerebrospinal fluid
Fluorescent Dyes
cerebrospinal fluid
mice
preparation
probes
Fluorescence
Proteins
proteins
fluorescence
tau Proteins
Amyloid beta-Peptides
Biomarkers
abdomen
biomarkers
Needles
Optical fibers
Blood
needles

Keywords

  • Alzheimer's early diagnostics
  • CSF biomarkers
  • Disease markers
  • Fluorescence

ASJC Scopus subject areas

  • Materials Science(all)
  • Instrumentation
  • Engineering(all)
  • Process Chemistry and Technology
  • Computer Science Applications
  • Fluid Flow and Transfer Processes

Cite this

@article{cb2f1d077d014ce6ad62de645ac5731a,
title = "Quantification of two fluorophores' concentration ratio in a mice model in preparation for a proposed method for early detection of Alzheimer's disease",
abstract = "Many biomedical applications require concentration measurements of biological compounds, which may be achieved using targeted fluorescent probes. It has been shown that the ratio between amyloid-Beta and tau protein in the cerebrospinal fluid (CSF) is a good indicator of incipient Alzheimer's disease (AD).We have previously proposed a method that can accurately estimate the concentration ratio of these two proteins without the need to collect CSF samples: Fluorescent probes are injected to the blood and bind to the CSF biomarkers. A miniature needle with an optical fiber excites the fluorescent probes and collects the fluorescence emission. The concentration ratio between the proteins is estimated, and used for diagnosis of incipient AD. We present here the results of the method's concentration ratio estimation during trials performed on mice. Miniature tubes containing two fluorescent probes in several concentration ratios were implanted in two locations in the mice: subcutaneously, and deeper in the abdomen. The fluorescent probes were excited and the fluorescence intensity was measured. The concentration ratios were estimated from the fluorescence intensities with an average error of less than 20{\%}. This study is a step towards the demonstration of the method in in vivo studies in mice with markers in the bloodstream/CSF.",
keywords = "Alzheimer's early diagnostics, CSF biomarkers, Disease markers, Fluorescence",
author = "Osnat Harbater and Margalit Efrati and Israel Gannot",
year = "2018",
month = "5",
day = "8",
doi = "10.3390/app8050745",
language = "English (US)",
volume = "8",
journal = "Applied Sciences (Switzerland)",
issn = "2076-3417",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "5",

}

TY - JOUR

T1 - Quantification of two fluorophores' concentration ratio in a mice model in preparation for a proposed method for early detection of Alzheimer's disease

AU - Harbater, Osnat

AU - Efrati, Margalit

AU - Gannot, Israel

PY - 2018/5/8

Y1 - 2018/5/8

N2 - Many biomedical applications require concentration measurements of biological compounds, which may be achieved using targeted fluorescent probes. It has been shown that the ratio between amyloid-Beta and tau protein in the cerebrospinal fluid (CSF) is a good indicator of incipient Alzheimer's disease (AD).We have previously proposed a method that can accurately estimate the concentration ratio of these two proteins without the need to collect CSF samples: Fluorescent probes are injected to the blood and bind to the CSF biomarkers. A miniature needle with an optical fiber excites the fluorescent probes and collects the fluorescence emission. The concentration ratio between the proteins is estimated, and used for diagnosis of incipient AD. We present here the results of the method's concentration ratio estimation during trials performed on mice. Miniature tubes containing two fluorescent probes in several concentration ratios were implanted in two locations in the mice: subcutaneously, and deeper in the abdomen. The fluorescent probes were excited and the fluorescence intensity was measured. The concentration ratios were estimated from the fluorescence intensities with an average error of less than 20%. This study is a step towards the demonstration of the method in in vivo studies in mice with markers in the bloodstream/CSF.

AB - Many biomedical applications require concentration measurements of biological compounds, which may be achieved using targeted fluorescent probes. It has been shown that the ratio between amyloid-Beta and tau protein in the cerebrospinal fluid (CSF) is a good indicator of incipient Alzheimer's disease (AD).We have previously proposed a method that can accurately estimate the concentration ratio of these two proteins without the need to collect CSF samples: Fluorescent probes are injected to the blood and bind to the CSF biomarkers. A miniature needle with an optical fiber excites the fluorescent probes and collects the fluorescence emission. The concentration ratio between the proteins is estimated, and used for diagnosis of incipient AD. We present here the results of the method's concentration ratio estimation during trials performed on mice. Miniature tubes containing two fluorescent probes in several concentration ratios were implanted in two locations in the mice: subcutaneously, and deeper in the abdomen. The fluorescent probes were excited and the fluorescence intensity was measured. The concentration ratios were estimated from the fluorescence intensities with an average error of less than 20%. This study is a step towards the demonstration of the method in in vivo studies in mice with markers in the bloodstream/CSF.

KW - Alzheimer's early diagnostics

KW - CSF biomarkers

KW - Disease markers

KW - Fluorescence

UR - http://www.scopus.com/inward/record.url?scp=85047004477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047004477&partnerID=8YFLogxK

U2 - 10.3390/app8050745

DO - 10.3390/app8050745

M3 - Article

AN - SCOPUS:85047004477

VL - 8

JO - Applied Sciences (Switzerland)

JF - Applied Sciences (Switzerland)

SN - 2076-3417

IS - 5

M1 - 745

ER -